Literature DB >> 10740984

Measuring neuropsychological change in schizophrenia with novel antipsychotic medications.

S E Purdon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10740984      PMCID： PMC1408057     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  44 in total

1.  MENTAL DETERIORATION IN CHRONIC SCHIZOPHRENIA.

Authors:  A SMITH
Journal:  J Nerv Ment Dis       Date:  1964-11       Impact factor: 2.254

2.  Intellectual loss in schizophrenia. II.

Authors:  A E SCHWARTZMAN; V I DOUGLAS; W R MUIR
Journal:  Can J Psychol       Date:  1962-06

3.  Seroquel and cognitive improvement in patients with schizophrenia.

Authors:  E Stip; I Lussier; M Babai; J L Fabian; C Link
Journal:  Biol Psychiatry       Date:  1996-09-01       Impact factor: 13.382

4.  Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study.

Authors:  J A Sweeney; G L Haas; J G Keilp; M Long
Journal:  Psychiatry Res       Date:  1991-07       Impact factor: 3.222

5.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Neuropsychological discriminators of long-term inpatient or outpatient status in chronic schizophrenia.

Authors:  D Perlick; S Mattis; P Stastny; J Teresi
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

Review 8.  Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.

Authors:  G Cassens; A K Inglis; P S Appelbaum; T G Gutheil
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

9.  Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients.

Authors:  B Kolb; I Q Whishaw
Journal:  J Nerv Ment Dis       Date:  1983-07       Impact factor: 2.254

10.  A neuropsychological study of early onset schizophrenia.

Authors:  A L Hoff; D Harris; W O Faustman; M Beal; D DeVilliers; R D Mone; J A Moses; J G Csernansky
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939
View more
  9 in total

1.  A short form of the Wisconsin Card Sorting Test.

Authors:  S E Purdon; B Waldie
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

3.  Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study.

Authors:  Margot Albus; Werner Hubmann; Fritz Mohr; Susanne Hecht; Petra Hinterberger-Weber; Nichi-Niels Seitz; Helmut Küchenhoff
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-10-09       Impact factor: 5.270

Review 4.  Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms.

Authors:  Fabio Fumagalli; Angelisa Frasca; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 5.  Atypical antipsychotic-induced metabolic disturbances in the elderly.

Authors:  Melanie Dawn Guenette; Araba Chintoh; Gary Remington; Margaret Hahn
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

6.  Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.

Authors:  S E Purdon; A Malla; A Labelle; W Lit
Journal:  J Psychiatry Neurosci       Date:  2001-03       Impact factor: 6.186

7.  Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.

Authors:  E M Meisenzahl; J Scheuerecker; M Zipse; S Ufer; M Wiesmann; T Frodl; N Koutsouleris; T Zetzsche; G Schmitt; M Riedel; I Spellmann; S Dehning; J Linn; H Brückmann; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-06       Impact factor: 5.270

Review 8.  Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics.

Authors:  John G Csernansky; Emily K Schuchart
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 9.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.